Your search returned 62 studies. (Get alerts for new studies):
- Study of the T-cells or EBV Specific CTLs for Advanced B-Cell Non Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia
Conditions: Non-Hodgkin Lymphoma - Chronic Lymphocytic Leukemia
2 Locations available
- Vorinostat in Patients With Primary Cutaneous T-Cell Lymphoma
Conditions: Stage I Cutaneous T-cell Non-Hodgkin Lymphoma - Stage I Mycosis Fungoides/Sezary Syndrome - Stage II Cutaneous T-cell Non-Hodgkin Lymphoma - Stage II Mycosis Fungoides/Sezary Syndrome - Stage III Cutaneous T-cell Non-Hodgkin Lymphoma - Stage III Mycosis F
1 Location available
- Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL
Conditions: Relapsed T-Cell Acute Lymphoblastic Leukemia - Relapsed T-Cell Lymphoblastic Lymphoma
20 Locations available
- EPOCH Chemotherapy and Bortezomib for Associated T-Cell Leukemia Lymphoma
Conditions: Leukemia-Lymphoma, Adult T-Cell
3 Locations available
- Lenalidomide as Maintenance Therapy After Combination Chemotherapy With or Without Rituximab and Stem Cell Transplant in Treating Patients With Persis
Conditions: Adult Nasal Type Extranodal NK/T-cell Lymphoma - Anaplastic Large Cell Lymphoma - Angioimmunoblastic Lymphadenopathy - Mucosa-Associated Lymphoid Tissue Lymphoma - Monocytoid B-cell Lymphoma - Peripheral T-cell Lymphoma - Recurrent Adult Burkitt's Lymphom
1 Location available
- Phase 1 Nilotinib in Steroid Dependent/Refractory Chronic Graft Versus Host Disease
Conditions: Blood and Marrow Transplant (BMT) - Lymphomas: Non-Hodgkin - Peripheral T-Cell
2 Locations available
- Panobinostat in Treating Patients With Relapsed or Refractory Non-Hodgkin Lymphoma
Conditions: Adult Nasal Type Extranodal NK/T-cell Lymphoma - Anaplastic Large Cell Lymphoma - Angioimmunoblastic T-cell Lymphoma - Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue - Hepatosplenic T-cell Lymphoma - Nodal Marginal Zone B-ce
2 Locations available
- Blood and Tissue Collection for Cutaneous Lymphoma Research
Conditions: Cutaneous T-Cell Lymphoma - Sezary Syndrome - Mycosis Fungoides
1 Location available
- Bendamustine Hydrochloride, Etoposide, Dexamethasone, and Filgrastim For Peripheral Blood Stem Cell Mobilization in Treating Patients With Refractory
Conditions: Adult Nasal Type Extranodal NK/T-cell Lymphoma - Anaplastic Large Cell Lymphoma - Angioimmunoblastic T-cell Lymphoma - Cutaneous B-cell Non-Hodgkin Lymphoma - Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue - Intraocular Lymp
1 Location available
- A Phase 1 Study of Brentuximab Vedotin Given Sequentially and Combined With Multi-Agent Chemotherapy for CD30-Positive Mature T-Cell and NK-Cell Neopl
Conditions: Lymphoma, Large-Cell, Anaplastic - Lymphoma, NK-cell - Lymphoma, T-cell
9 Locations available
- Study of Pralatrexate Versus Observation Following CHOP-based Chemotherapy in Previously Undiagnosed Peripheral T-cell Lymphoma Patients
Conditions: Peripheral T-cell Lymphoma
1 Location available
- Allogeneic Transplantation in Patients With Cutaneous T-Cell Lymphoma
Conditions: Lymphoma - Bone Marrow Transplantation
1 Location available
- T-Cell Depleted Allogeneic Stem Cell Transplantation for Patients With Hematologic Malignancies
Conditions: Acute Myelogenous Leukemia - Lymphoid Leukemia - Chronic Myelogenous Leukemia - Malignant Lymphoma - Hodgkin's Disease - Chronic Lymphocytic Leukemia - Myeloproliferative Disorder - Anemia, Aplastic - Myelodysplastic Syndromes
1 Location available
- Study Evaluating Two Dose Levels of Targretin Capsules in Patients With Refractory Cutaneous T-cell Lymphoma (CTCL)
Conditions: Refractory Cutaneous T-cell Lymphoma
17 Locations available
- Rituximab in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer
Conditions: Leukemia, Myeloid, Accelerated Phase - Adult Acute Lymphoblastic Leukemia in Remission - Adult Acute Myeloid Leukemia in Remission - Adult Nasal Type Extranodal NK/T-cell Lymphoma - Blast Phase - Contiguous Stage II Adult Burkitt's Lymphoma - Contiguous S
1 Location available
- Prospective Collection of Data in Patients With Peripheral T-Cell Lymphoma
Conditions: Lymphoma, T-Cell, Peripheral
4 Locations available
- Extension Study in Subjects Who Relapsed After Complete Response on Study KW-0761-001
Conditions: Peripheral T-cell Lymphoma - Cutaneous T-cell Lymphoma
1 Location available
- Etoposide, Filgrastim, and Plerixafor in Improving Stem Cell Mobilization in Treating Patients With Non-Hodgkin Lymphoma
Conditions: Adult Nasal Type Extranodal NK/T-cell Lymphoma - Anaplastic Large Cell Lymphoma - Angioimmunoblastic T-cell Lymphoma - Cutaneous B-cell Non-Hodgkin Lymphoma - Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue - Hepatosplenic T-
1 Location available
- A Pilot Study to Determine the Safety of the Combination of Ontak in Combination With CHOP in Peripheral T-Cell Lymphoma
Conditions: Peripheral T-Cell Lymphoma
1 Location available
- Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma
Conditions: Leukemia - Lymphoma
172 Locations available
- SAHA + CHOP in Untreated T-cell Non-Hodgkin's Lymphoma
Conditions: Lymphoma
1 Location available
- Siplizumab, Combination Chemotherapy, and Rituximab in Treating Patients With T-Cell or Natural Killer-Cell Non-Hodgkin Lymphoma
Conditions: Lymphoma
2 Locations available
- Iodine I 131 Monoclonal Antibody BC8 Before Autologous Stem Cell Transplant in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-H
Conditions: Adult Nasal Type Extranodal NK/T-cell Lymphoma - Anaplastic Large Cell Lymphoma - Angioimmunoblastic T-cell Lymphoma - Cutaneous B-cell Non-Hodgkin Lymphoma - Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue - Hepatosplenic T-
1 Location available
- Pralatrexate and Bexarotene in Patients With Relapsed or Refractory Cutaneous T-cell Lymphoma
Conditions: Cutaneous T-cell Lymphoma - Mycosis Fungoides - Sezary Syndrome - Primary Cutaneous Anaplastic Large Cell Lymphoma
3 Locations available
- Lenalidomide With or Without Rituximab in Treating Patients With Progressive or Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Pro
Conditions: Adult Nasal Type Extranodal NK/T-cell Lymphoma - Anaplastic Large Cell Lymphoma - Angioimmunoblastic T-cell Lymphoma - Cutaneous B-cell Non-Hodgkin Lymphoma - Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue - Hepatosplenic T-
1 Location available
- Topical Romidepsin in Treating Patients With Stage I or Stage II Cutaneous T-Cell Non-Hodgkin's Lymphoma
Conditions: Lymphoma
1 Location available
- Pilot Study of Expanded, Donor Natural Killer Cell Infusions for Refractory Non-B Lineage Hematologic Malignancies and Solid Tumors
Conditions: Leukemia, Myeloid, Acute - Leukemia, Lymphocytic, Acute, T-Cell - Juvenile Myelomonocytic Leukemia Lymphoblastic - T-cell Lymphoblastic Lymphoma - Myelodysplastic Syndrome
1 Location available
- Busulfan-fludarabine Conditioning and T-cell Depleted Allogeneic Stem Cell Transplantation for Patients With Advanced Hematologic Malignancies
Conditions: Leukemia - Lymphoma - Myeloma
1 Location available
- Everolimus and Lenalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin or Hodgkin Lymphoma
Conditions: Adult Nasal Type Extranodal NK/T-cell Lymphoma - Anaplastic Large Cell Lymphoma - Angioimmunoblastic T-cell Lymphoma - Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue - Hepatosplenic T-cell Lymphoma - Nodal Marginal Zone B-ce
2 Locations available
- Bortezomib and Azacitidine in Treating Patients With Relapsed or Refractory T-Cell Lymphoma
Conditions: Adult Nasal Type Extranodal NK/T-cell Lymphoma - Anaplastic Large Cell Lymphoma - Angioimmunoblastic T-cell Lymphoma - Hepatosplenic T-cell Lymphoma - Peripheral T-cell Lymphoma - Post-transplant Lymphoproliferative Disorder - Prolymphocytic Leukemia - Re
1 Location available
- AR-42 in Treating Patients With Advanced or Relapsed Multiple Myeloma, Chronic Lymphocytic Leukemia, or Lymphoma
Conditions: Adult Nasal Type Extranodal NK/T-cell Lymphoma - Anaplastic Large Cell Lymphoma - Angioimmunoblastic T-cell Lymphoma - Cutaneous B-cell Non-Hodgkin Lymphoma - Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue - Hepatosplenic T-
1 Location available
- Tandem Auto-Allo Transplant for Lymphoma
Conditions: Diffuse, Large B-Cell, Lymphoma - Lymphoma, Low-Grade - T-Cell Lymphoma - Mantle-Cell Lymphoma - Hodgkin's Lymphoma - Chronic Lymphocytic Leukemia - Lymphoma, Small Lymphocytic
2 Locations available
- Lenalidomide in HTLV-1 Adult T-Cell Leukemia
Conditions: Adult T Cell Leukemia/Lymphoma
1 Location available
- Carfilzomib in Treating Patients With Relapsed or Refractory T-Cell Lymphoma
Conditions: Adult Nasal Type Extranodal NK/T-cell Lymphoma - Anaplastic Large Cell Lymphoma - Angioimmunoblastic T-cell Lymphoma - Peripheral T-cell Lymphoma - Recurrent Adult T-cell Leukemia/Lymphoma
1 Location available
- Combination Chemotherapy and Pralatrexate as First-Line Therapy in Treating Patients With Non-Hodgkin Lymphoma
Conditions: Anaplastic Large Cell Lymphoma - Angioimmunoblastic T-cell Lymphoma - Hepatosplenic T-cell Lymphoma - Peripheral T-cell Lymphoma
4 Locations available
- Alisertib (MLN8237) or Investigator's Choice in Patients With Relapsed/Refractory Peripheral T-Cell Lymphoma
Conditions: Relapsed Peripheral T-Cell Lymphoma - Refractory Peripheral T-Cell Lymphoma
8 Locations available
- A Study of the Histone Deacetylase Inhibitor (HDACi) JNJ-26481585 in Patients With Previously Treated Stage Ib-IVa Cutaneous T-cell Lymphoma (CTCL)
Conditions: Cutaneous T-cell Lymphoma; Histone Deacetylase Inhibitor; Lymphoma; Oncology
1 Location available
- Autologous Stem Cell Transplant Followed By Donor Stem Cell Transplant In Treating Patients With Relapsed or Refractory Lymphoma
Conditions: Adult Nasal Type Extranodal NK/T-cell Lymphoma - Anaplastic Large Cell Lymphoma - Angioimmunoblastic T-cell Lymphoma - Burkitt Lymphoma - Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue - Nodal Marginal Zone B-cell Lymphoma -
2 Locations available
- Ph II of Non-myeloablative Allogeneic Transplantation Using TLI & ATG In Patients w/ Cutaneous T Cell Lymphoma
Conditions: Mycoses - Sezary Syndrome - Lymphoma, T-Cell, Cutaneous - Bone Marrow Transplant Failure - Lymphoma, Non-Hodgkin - Cutaneous T-cell Lymphoma of Skin
1 Location available
- O6-Benzylguanine and Topical Carmustine in Early-Stage(IA-IIA) Cutaneous T-Cell Lymphoma
Conditions: Lymphoma
1 Location available
- Immune Response After Stem Cell Transplant in HIV-Positive Patients With Hematologic Cancer
Conditions: Accelerated Phase Chronic Myelogenous Leukemia - Adult Acute Lymphoblastic Leukemia in Remission - Adult Acute Myeloid Leukemia in Remission - Adult Nasal Type Extranodal NK/T-cell Lymphoma - AIDS-related Diffuse Large Cell Lymphoma - AIDS-related Diffuse
1 Location available
- Haploidentical Allogeneic Transplant w/Post Transplant Infusion of Regulatory T-cells (BMT Protocol 204)
Conditions: Leukemia - Leukemia Chronic Myelogenous Leukemia (CML) - Blood and Marrow Transplant (BMT) - Myelodysplastic Syndromes (MDS) - Lymphomas: Non-Hodgkin
1 Location available
- TLR8 Agonist VTX-2337 in Combo With Local Radiation in Low-Grade B-cell Lymphomas
Conditions: Lymphoma, Non-Hodgkin - Cutaneous Lymphoma - Large B Cell Diffuse Lymphoma - Mantle Cell Lymphoma - Marginal Zone B-Cell Lymphoma - Peripheral T-cell Lymphoma, Large Cell - Waldenstrom Macroglobulinemia
1 Location available
- Ruxolitinib Phosphate (Oral JAK Inhibitor INCB18424) in Treating Patients With Relapsed or Refractory Diffuse Large B-Cell or Peripheral T-Cell Non-Ho
Conditions: Peripheral T-cell Lymphoma - Recurrent Adult Diffuse Large Cell Lymphoma - Recurrent Adult T-cell Leukemia/Lymphoma
1 Location available
- Outcomes of Cutaneous T-Cell Lymphoma and Graft-Versus-Host Disease With Extracorporeal Photopheresis Treatment
Conditions: Cutaneous T Cell Lymphoma - Graft Versus Host Disease
1 Location available
- A Pilot Study of Sorafenib Examining Biomarkers in Refractory or Relapsed T-Cell Lymphoma Patients
Conditions: T Cell Lymphoma
1 Location available
- LMP-specific T-cells for Patients With Relapsed EBV-positive Lymphoma
Conditions: Hodgkin Disease - Non Hodgkin Lymphoma
3 Locations available
- A-dmDT390-bisFv (UCHT1) Immunotoxin Therapy for Patients With T-cell Diseases
Conditions: T-cell Lymphomas - T-cell Leukemia - Sezary Syndrome - Mycosis Fungoides
1 Location available
- T-cell Recovery in Patients With Leukemia, Advanced Lymphoma, Myelodysplastic Syndrome, or Myeloproliferative Disorder Receiving Alemtuzumab and Under
Conditions: Chronic Myeloproliferative Disorders - Leukemia - Lymphoma - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms
2 Locations available
- Panobinostat and Everolimus in Treating Patients With Recurrent Multiple Myeloma, Non-Hodgkin Lymphoma, or Hodgkin Lymphoma
Conditions: Hematopoietic/Lymphoid Cancer - Adult Nasal Type Extranodal NK/T-cell Lymphoma - Anaplastic Large Cell Lymphoma - Angioimmunoblastic T-cell Lymphoma - B-cell Adult Acute Lymphoblastic Leukemia - Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associate
2 Locations available
- Comprehensive Oncology Measures for Peripheral T-cell Lymphoma Treatment Registry
Conditions: Peripheral T-cell Lymphoma
65 Locations available
- Safety, Pharmacodynamics (PD), Pharmacokinetics (PK) Study of SHP141 in 1A, 1B, or 2A Cutaneous T-Cell Lymphoma (CTCL)
Conditions: Lymphoma, T-Cell, Cutaneous
4 Locations available
- A Phase 3 Trial of Brentuximab Vedotin(SGN-35) Versus Physician's Choice (Methotrexate or Bexarotene) in Patients With CD30-Positive Cutaneous T-Cell
Conditions: Primary Cutaneous Anaplastic Large Cell Lymphoma, - Mycosis Fungoides
1 Location available
- Recalcitrant Pruritus in Cutaneous T-Cell Lymphoma
Conditions: Cutaneous T-Cell Lymphoma
1 Location available
- T-cell Depleted Alternative Donor Transplantation
Conditions: Acute Lymphoblastic Leukemia - Acute Myeloid Leukemia - Chronic Myeloid Leukemia - Myelodysplastic Syndrome - Lymphomas - Bone Marrow Failure - Hemoglobinopathy - Immune Deficiency - Osteopetrosis
1 Location available
- Autologous Peripheral Blood Stem Cell Transplant Followed by Donor Bone Marrow Transplant in Treating Patients With High-Risk Hodgkin Lymphoma, Non-Ho
Conditions: Adult Nasal Type Extranodal NK/T-cell Lymphoma - Anaplastic Large Cell Lymphoma - Angioimmunoblastic T-cell Lymphoma - B-cell Chronic Lymphocytic Leukemia - Burkitt Lymphoma - Childhood Diffuse Large Cell Lymphoma - Childhood Immunoblastic Large Cell Lymp
2 Locations available
- Bendamustine Hydrochloride, Rituximab, Etoposide, and Carboplatin in Treating Patients With Relapsed or Refractory Lymphoid Malignancies and Select Un
Conditions: Adult Grade III Lymphomatoid Granulomatosis - Adult Nasal Type Extranodal NK/T-cell Lymphoma - Anaplastic Large Cell Lymphoma - Angioimmunoblastic T-cell Lymphoma - Chronic Lymphocytic Leukemia - Contiguous Stage II Adult Diffuse Mixed Cell Lymphoma - Con
1 Location available
- SGN-35 in CD30-positive Lymphoproliferative Disorders (ALCL), Mycosis Fungoides (MF), and Extensive Lymphomatoid Papulosis (LyP)
Conditions: CD-30 Positive Anaplastic Large T-cell Cutaneous Lymphoma - Lymphoma, Primary Cutaneous Anaplastic Large Cell - Lymphomatoid Papulosis - Mycosis Fungoides - Skin Lymphoma - Cutaneous Lymphomas - Lymphoma - Hematologic Disorder
1 Location available
- Study to Evaluate the Safety and Tolerability of Weekly Intravenous (IV) Doses of BMS-906024 in Subjects With Acute T-cell Lymphoblastic Leukemia or T
Conditions: Lymphoblastic Leukemia, Acute T-cell - Precursor T-Cell Lymphoblastic Lymphoma
3 Locations available
- A Study of Brentuximab Vedotin in Patients With CD30-positive Non-Hodgkin Lymphoma
Conditions: Lymphoma, B-Cell - Lymphoma, Non-Hodgkin - Lymphoma, T-Cell
15 Locations available
- Topical Romidepsin to Treat Early-Stage Cutaneous T-Cell Lymphoma
Conditions: Mycosis Fungoides - Cutaneous T-Cell Lymphoma - Neoplasms
1 Location available
- Alisertib in Treating Patients With Relapsed or Refractory Peripheral T-Cell Non-Hodgkin Lymphoma
Conditions: Lymphoma
126 Locations available
|